This hypothesis is consistent with recent evidence showing that aberrant S-nitrosylation in hepatocellular carcinoma, due to GSNOR deficiency, results in mitochondrial alteration and parallel upregulation of succinate dehydrogenase levels and activity, this depending on TRAP1 S-nitrosylation and subsequent degradation [16]. This evidence concerns the gene ADH5 and hepatocellular carcinoma.